FITC-dextran gut permeability assay

JL Joshua D. G. Leach
NV Nikola Vlahov
PT Petros Tsantoulis
RR Rachel A. Ridgway
DF Dustin J. Flanagan
KG Kathryn Gilroy
NS Nathalie Sphyris
EV Ester G. Vázquez
DV David F. Vincent
WF William J. Faller
MH Michael C. Hodder
AR Alexander Raven
SF Sigrid Fey
AN Arafath K. Najumudeen
DS Douglas Strathdee
CN Colin Nixon
MH Mark Hughes
WC William Clark
RS Robin Shaw
SH Sander R. van Hooff
DH David J. Huels
JM Jan Paul Medema
SB Simon T. Barry
MF Margaret C. Frame
AU Asier Unciti-Broceta
SL Simon J. Leedham
GI Gareth J. Inman
RJ Rene Jackstadt
BT Barry J. Thompson
AC Andrew D. Campbell
ST Sabine Tejpar
OS Owen J. Sansom
request Request a Protocol
ask Ask a question
Favorite

Mice were induced with two injections of 3 mg (120 mg/kg) and 2 mg (80 mg/kg) tamoxifen on consecutive days. On day 7 post induction, mice were fasted for 12 h and then dosed with 600 mg/kg FITC-dextran (4 kDa; Sigma, #46944) by oral gavage. Mice were sacrificed and blood was sampled 4 h post gavage. Serum concentrations of FITC-dextran were determined using a fluorimeter (490/530 nm) against standard curves generated from the same stock solution used to dose the mice.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A